Panbela Therapeutics Inc expected to post a loss of 18 cents a share - Earnings Preview

Panbela Therapeutics

10/08/2021 24:49

* Panbela Therapeutics Inc  PBLA.OQ   PBLA.O  is expected
to report results on August 11.
​* Refinitiv's mean analyst estimate for Panbela Therapeutics
Inc is for a loss of 18 cents per share. 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Panbela
Therapeutics Inc is $9​, about 72.9% above​ its last closing
price of $2.44. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Mar. 31 2021  -0.11       -0.11      -0.23     Missed  -109.1
 Dec. 31 2020  -0.18       -0.16      -0.09     Beat    45.5
 Sep. 30 2020  -0.12       -0.12      -0.21     Missed  -75​
 ​​            ​                                        ​
                                                        ​
 This summary was machine generated August 9 at 23:49 GMT.  All
figures in US dollars unless otherwise stated